Nonenzymatic Protein Functions (1A)
Help Questions
MCAT Biological and Biochemical Foundations of Living Systems › Nonenzymatic Protein Functions (1A)
In cultured neurons, investigators expressed a membrane receptor whose cytosolic tail contains a short motif that binds an intracellular scaffold protein (Scaffold S). When the motif was deleted, ligand binding to the receptor at the cell surface was unchanged, but downstream signaling readouts (calcium transients) became smaller and more variable across trials. No enzymatic domains were altered in either protein. Which statement best describes the protein’s role in this system?
Scaffold S stabilizes receptor positioning and coupling to signaling complexes, improving signal reliability
Scaffold S catalyzes phosphorylation of the receptor tail, and deletion removes the catalytic site
Scaffold S increases ligand concentration by secreting ligand into the synaptic cleft
Scaffold S acts as the ligand and activates the receptor by binding its extracellular domain
Explanation
This question evaluates the nonenzymatic scaffolding function of intracellular proteins in organizing signaling complexes. Scaffold proteins like Scaffold S stabilize receptor positions and facilitate interactions without catalyzing reactions. In the neuronal model, deleting the binding motif disrupts Scaffold S's role in coupling the receptor to downstream signaling, reducing calcium transient reliability. Choice B is accurate as it describes how the scaffold improves signal consistency through structural organization. Choice D is misleading because it assumes catalytic activity in phosphorylation, which contradicts the nonenzymatic nature stated. To approach similar questions, note if ligand binding is unchanged to focus on post-binding organization. Verify by ensuring no enzymatic domains are mentioned, emphasizing structural roles.
A study of skeletal muscle cells examined oxygen delivery during repeated contractions. Researchers compared wild-type myoglobin to a mutant myoglobin with a reduced heme-pocket complementarity for O$_2$ (lower affinity) but unchanged expression level. Under identical perfusion, mutant cells developed earlier fatigue and showed a larger drop in intracellular O$_2$ near mitochondria during stimulation. Based on the scenario, which interaction is likely based on the protein’s known properties?
Mutant myoglobin relocates to the extracellular matrix to transport O$_2$ in blood plasma
Mutant myoglobin catalyzes O$_2$ production from water, compensating for reduced perfusion
Mutant myoglobin binds O$_2$ less effectively, reducing intracellular O$_2$ buffering and diffusion toward mitochondria
Mutant myoglobin increases O$_2$ affinity, preventing O$_2$ release to mitochondria during contraction
Explanation
This question assesses the nonenzymatic role of myoglobin in oxygen storage and facilitated diffusion in muscle cells. Myoglobin binds oxygen reversibly, acting as an intracellular buffer and transporter without enzymatic activity. In the skeletal muscle scenario, the mutant myoglobin's reduced affinity for O2 impairs its ability to hold and deliver oxygen to mitochondria during contractions. Choice A is correct because lower affinity decreases O2 buffering and diffusion, leading to earlier fatigue and intracellular O2 drops. Choice B is a distractor as it incorrectly suggests increased affinity would trap O2, but the mutation actually lowers affinity, not raises it. For similar problems, confirm if protein abundance is unchanged to isolate binding affinity effects. Always cross-check affinity changes with functional outcomes like delivery efficiency.
To evaluate antibody specificity, researchers tested binding of a monoclonal antibody (mAb) to a viral surface protein from two strains. The epitope differs by two amino acids between strains. ELISA showed strong binding to Strain 1 and minimal binding to Strain 2 under identical conditions. Neutralization assays mirrored the ELISA results. Which interaction is likely based on the protein’s known properties?
The mAb recognizes a conformational epitope whose altered residues in Strain 2 reduce complementarity and binding affinity
The mAb binds both strains equally, but only Strain 1 expresses enzymes needed for neutralization
The mAb binds Strain 2 more tightly, which explains the minimal ELISA signal due to faster dissociation
The mAb acts as a receptor that transports viral proteins into the cell, and the mutations block transport
Explanation
This question assesses nonenzymatic antibody-antigen specificity via epitope complementarity. Monoclonal antibodies bind conformational epitopes, with mutations reducing affinity if complementarity decreases. The two-amino-acid difference weakens mAb binding to Strain 2, mirroring reduced neutralization. Choice D accurately ties this to altered epitope residues lowering affinity. Choice C reverses binding strength, misreading ELISA signals. For antibody assays, correlate binding with functional outcomes like neutralization. Verify by noting minimal signal indicates poor binding, not tighter.
A cell biology lab investigated focal adhesions in migrating fibroblasts. They expressed a mutant integrin whose extracellular domain binds fibronectin normally, but whose cytoplasmic tail cannot bind talin. Cells expressing the mutant adhered weakly and generated less traction force, despite normal fibronectin coating and normal actin abundance. Based on the scenario, which interaction is likely based on the protein’s known properties?
Loss of integrin–talin binding increases fibronectin affinity, strengthening adhesion and traction
Talin is a secreted ligand for integrins, so tail mutation should not affect adhesion strength
Talin normally catalyzes fibronectin crosslinking outside the cell, so tail mutation reduces fibronectin polymerization
Loss of integrin–talin binding reduces linkage between extracellular matrix and actin cytoskeleton, weakening force transmission
Explanation
This question assesses the nonenzymatic linking function of integrins in focal adhesions. Integrins connect extracellular matrix to cytoskeleton via talin without enzymatic activity. The tail mutation disrupts talin binding, weakening adhesion and force transmission despite normal fibronectin interaction. Choice A is correct as it describes impaired linkage reducing traction. Choice C incorrectly adds extracellular catalysis, but talin is intracellular. To verify, check if extracellular binding is preserved to isolate intracellular defects. Use force-related outcomes to confirm mechanical roles.
In epithelial cells, a fluorescent glucose analog was taken up rapidly under baseline conditions. When extracellular Na$^+$ was replaced with an impermeant cation, uptake decreased markedly, but the plasma membrane expression of the glucose transporter (Transporter G) was unchanged. Based on the scenario, which outcome is most consistent with the transporter’s function?
Transporter G likely uses the Na$^+$ gradient to drive glucose uptake; removing Na$^+$ reduces cotransport-driven entry
Transporter G catalyzes conversion of glucose into a fluorescent product, and Na$^+$ is a required substrate
Transporter G pumps Na$^+$ out of the cell while exporting glucose, so Na$^+$ removal should increase uptake
Transporter G is a simple diffusion channel for glucose, so Na$^+$ removal should not affect uptake
Explanation
This question evaluates the nonenzymatic cotransport function of glucose transporters using ion gradients. Transporter G couples glucose uptake to Na+ influx, driven by the Na+ gradient without direct ATP use. Removing extracellular Na+ halts this secondary active transport, reducing uptake despite stable expression. Choice A is correct as it describes gradient-dependent cotransport. Choice B ignores the Na+ dependence, assuming passive diffusion. In uptake experiments, test ion substitutions to identify cotransporters. Confirm by noting unchanged expression isolates functional dependence.
A virology group examined viral entry mediated by a viral surface protein that binds a host cell receptor. A host receptor mutant lacking its extracellular binding site showed normal expression at the plasma membrane but markedly reduced viral attachment and entry. No intracellular signaling defects were detected during the short attachment assay. Based on the scenario, which outcome is most consistent with the receptor’s function in this context?
The receptor’s extracellular domain provides a specific binding site required for viral attachment, enabling subsequent entry steps
The receptor is a soluble ligand secreted by the host cell; deleting the binding site increases viral binding
The receptor catalyzes viral genome replication at the membrane, and loss of the binding site blocks catalysis
The receptor’s main role is nuclear transport of viral proteins; extracellular binding is irrelevant to attachment
Explanation
This question tests the nonenzymatic protein function of receptors in facilitating ligand binding, specifically in the context of viral attachment to host cells. Nonenzymatic protein functions include providing structural binding sites for ligands without catalyzing reactions, such as receptors that enable specific interactions between viruses and host cell surfaces. In this scenario, the host receptor's extracellular domain serves as a binding site for the viral surface protein, which is essential for viral attachment and subsequent entry into the cell. The correct answer, choice D, follows because the mutant receptor lacking the extracellular binding site shows reduced viral attachment despite normal membrane expression, indicating that the binding function is critical for entry without involvement in signaling during the short assay. A common distractor, such as choice B, is incorrect because it assumes an enzymatic role in catalyzing genome replication, which contradicts the lack of signaling defects and misattributes catalytic activity to a nonenzymatic binding function. To verify similar questions, always distinguish between enzymatic and nonenzymatic roles by checking if the protein's function involves catalysis or merely binding/support. Additionally, evaluate experimental outcomes like mutant effects to confirm the primary function, ensuring it aligns with observed deficits in attachment rather than unrelated processes.
Researchers studied epithelial polarity by tagging E-cadherin at adherens junctions. A mutation in E-cadherin’s extracellular domain reduced homophilic binding, leading to fragmented cell-cell contacts and increased cell scattering, while intracellular binding to catenins was preserved. Based on the scenario, which statement best describes the protein’s role in this system?
E-cadherin catalyzes extracellular matrix degradation to allow cells to separate
E-cadherin mediates calcium-dependent cell-cell adhesion via homophilic extracellular interactions, promoting tissue cohesion
E-cadherin’s primary role is to bind DNA in the nucleus to activate adhesion genes
E-cadherin functions as an ion pump that maintains polarity by exporting Na$^+$
Explanation
This question tests the nonenzymatic adhesive function of cadherins in cell junctions. E-cadherin forms homophilic bonds extracellularly to maintain contacts, calcium-dependently, without catalysis. The domain mutation weakens binding, causing scattering despite intracellular preservation. Choice D correctly describes adhesion via homophilic interactions. Choice B wrongly assigns matrix degradation. In polarity assays, observe contact integrity post-mutation. Differentiate extra- vs. intracellular domains for function.
A pharmacology group tested a competitive antagonist (Antag) for a G protein-coupled receptor (GPCR) in smooth muscle. Antag alone produced no response but shifted the agonist dose-response curve to the right without changing maximal response when high agonist concentrations were used. The GPCR is not an enzyme. Which statement best describes the protein’s role in this system?
The GPCR binds agonist to initiate signaling; Antag reduces apparent agonist potency by competing for the binding site
The GPCR is a transporter that imports agonist; Antag blocks import, eliminating all responses at any agonist dose
The GPCR catalyzes agonist synthesis; Antag inhibits catalysis, lowering maximal response
Antag is the receptor and the GPCR is the ligand; competition shifts the curve by increasing receptor abundance
Explanation
This question evaluates nonenzymatic ligand binding in GPCR signaling. GPCRs bind agonists to activate pathways; competitive antagonists occupy sites, shifting dose-responses rightward without max change. Antag competes without response, consistent with nonenzymatic binding competition. Choice D is correct as it describes site competition reducing potency. Choice B wrongly adds catalysis to the GPCR. In pharmacology, analyze curve shifts for competitive vs. noncompetitive. Verify max response to distinguish antagonism types.
In an ex vivo airway epithelium model, investigators tracked mucus clearance by imaging fluorescent beads placed on the apical surface. They applied a small molecule (Drug X) that binds polymerized actin (F-actin) with high affinity but does not bind actin monomers (G-actin). After Drug X treatment, bead transport speed decreased, and high-speed video showed reduced ciliary beat amplitude without major changes in ATP levels. Based on this scenario, which outcome is most consistent with F-actin’s nonenzymatic role in this system?
Reduced mechanical support for the apical cortex, limiting effective transmission of ciliary forces to the mucus layer
Increased microtubule polymerization in cilia due to direct activation of tubulin by F-actin
Enhanced secretion of mucins from the nucleus due to actin-mediated transcriptional catalysis
Decreased hydrolysis of ATP by actin, reducing energy available for ciliary beating
Explanation
This question tests the nonenzymatic function of actin filaments in providing mechanical support within cellular structures. F-actin, the polymerized form of actin, contributes to cytoskeletal integrity and force transmission without catalyzing reactions. In this airway epithelium model, Drug X binds F-actin, likely disrupting its structural role in the apical cortex that supports ciliary movement. The reduced bead transport and ciliary beat amplitude, despite unchanged ATP levels, align with choice B, as weakened mechanical support impairs the transmission of ciliary forces to the mucus layer. A common distractor like choice C is incorrect because it misattributes ATP hydrolysis to actin itself, confusing actin's nonenzymatic role with myosin's enzymatic activity in contraction. To verify similar questions, assess whether outcomes stem from structural disruption rather than energy depletion. A useful strategy is to check if ATP levels are mentioned as unchanged, pointing toward nonenzymatic mechanical functions over catalytic ones.
A neuroscience group studied axonal transport by imaging fluorescently labeled vesicles moving along microtubules. When cells were treated with a drug that destabilizes microtubules, vesicle movement became largely diffusive and showed frequent pauses; actin filaments were unaffected. ATP levels remained normal. Based on this scenario, which statement best describes the protein’s role in this system?
Microtubules function as membrane channels that allow vesicles to pass through the plasma membrane
Microtubules inhibit vesicle movement by binding vesicles nonspecifically, so destabilization should increase directed transport
Microtubules directly synthesize ATP needed for vesicle transport, and destabilization lowers ATP production
Microtubules provide polarized tracks that support directed vesicle transport; destabilization disrupts long-range delivery
Explanation
This question tests the nonenzymatic function of microtubules as tracks for intracellular transport. Microtubules provide polarized scaffolds for motor-driven vesicle movement without catalytic roles. Destabilizing microtubules shifts vesicle transport from directed to diffusive, with pauses, despite normal ATP and actin. Choice C correctly identifies this track disruption impairing long-range delivery. Choice B wrongly assigns ATP synthesis to microtubules, confusing them with mitochondria. In similar experiments, observe movement patterns to distinguish directed vs. random motion. Verify by confirming unaffected components like ATP to isolate structural effects.